{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=DPH+50+mg&page=2", "query": { "intervention": "DPH 50 mg", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=DPH+50+mg&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-09-27T19:11:12.618Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT03331042", "title": "SM-1 vs 2 Comparators and Placebo in Participants With a History of Transient Insomnia.", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Transient Insomnia" ], "interventions": [ { "name": "SM-1", "type": "DRUG" }, { "name": "D+Z", "type": "DRUG" }, { "name": "D+L", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sequential Medicine Ltd", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 85, "start_date": "2017-10-09", "completion_date": "2018-03-22", "has_results": true, "last_update_posted_date": "2019-06-05", "last_synced_at": "2026-09-27T19:11:12.618Z", "location_count": 2, "location_summary": "Atlanta, Georgia • New York, New York", "locations": [ { "city": "Atlanta", "state": "Georgia" }, { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT03331042" }, { "nct_id": "NCT07542756", "title": "A SMART Approach to Evaluating the Benefits of Common Prescription and OTC Medications for Insomnia", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Insomnia", "Insomnia Disorder", "Chronic Insomnia", "Chronic Insomnia Disorder" ], "interventions": [ { "name": "Sleep Hygiene Education", "type": "OTHER" }, { "name": "Melatonin IR, 3 mg", "type": "DIETARY_SUPPLEMENT" }, { "name": "Melatonin IR, 5 mg", "type": "DIETARY_SUPPLEMENT" }, { "name": "Diphenhydramine, 25 mg", "type": "DRUG" }, { "name": "Diphenhydramine, 50 mg", "type": "DRUG" }, { "name": "Doxepin, 3 mg", "type": "DRUG" }, { "name": "Doxepin, 6 mg", "type": "DRUG" }, { "name": "Trazodone, 50 mg", "type": "DRUG" }, { "name": "Trazodone, 100 mg", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Zolpidem, 5 mg", "type": "DRUG" }, { "name": "Zolpidem, 10 mg", "type": "DRUG" } ], "intervention_types": [ "OTHER", "DIETARY_SUPPLEMENT", "DRUG" ], "sponsor": "University of Pennsylvania", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 1200, "start_date": "2026-05-01", "completion_date": "2032-01-01", "has_results": false, "last_update_posted_date": "2026-09-16", "last_synced_at": "2026-09-27T19:11:12.618Z", "location_count": 1, "location_summary": "Philadelphia, Pennsylvania", "locations": [ { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT07542756" }, { "nct_id": "NCT01118273", "title": "Evaluate Analgesic/Sedative Efficacy of Naproxen Sodium and Diphenhydramine", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Sleep" ], "interventions": [ { "name": "Naproxen Sodium 440 mg (BAYH6689) / DPH 50mg", "type": "DRUG" }, { "name": "Naproxen Sodium 440 mg (BAYH6689)", "type": "DRUG" }, { "name": "Naproxen Sodium 220 mg (BAYH6689) / DPH 50mg", "type": "DRUG" }, { "name": "Naproxen Sodium 220 mg (BAYH6689)", "type": "DRUG" }, { "name": "DPH 50mg", "type": "DRUG" }, { "name": "Ibuprofen 400 mg / Diphenhydramine citrate 76 mg", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Bayer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "16 Years", "maximum_age": "45 Years", "sex": "ALL", "summary": "16 Years to 45 Years" }, "enrollment_count": 162, "start_date": "2008-01", "completion_date": "2008-02", "has_results": true, "last_update_posted_date": "2015-06-08", "last_synced_at": "2026-09-27T19:11:12.618Z", "location_count": 1, "location_summary": "Salt Lake City, Utah", "locations": [ { "city": "Salt Lake City", "state": "Utah" } ], "official_url": "https://clinicaltrials.gov/study/NCT01118273" }, { "nct_id": "NCT01158820", "title": "Alternative Sedation During Bronchoscopy", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Sedation" ], "interventions": [ { "name": "Dexmedetomidine load", "type": "DRUG" }, { "name": "Ketamine load", "type": "DRUG" }, { "name": "Midazolam load", "type": "DRUG" }, { "name": "Fentanyl load", "type": "DRUG" }, { "name": "Dexmedetomidine maintenance", "type": "DRUG" }, { "name": "Ketamine maintenance", "type": "DRUG" }, { "name": "Midazolam demand", "type": "DRUG" }, { "name": "Fentanyl demand", "type": "DRUG" }, { "name": "Benadryl demand", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Pennsylvania", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "90 Years", "sex": "ALL", "summary": "18 Years to 90 Years" }, "enrollment_count": 50, "start_date": "2010-06", "completion_date": "2012-05", "has_results": true, "last_update_posted_date": "2019-02-26", "last_synced_at": "2026-09-27T19:11:12.618Z", "location_count": 1, "location_summary": "Philadelphia, Pennsylvania", "locations": [ { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT01158820" }, { "nct_id": "NCT00723801", "title": "Effects of Losartan Versus Atenolol on Aortic and Cardiac Muscle Stiffness in Adults With Marfan Syndrome", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Marfan Syndrome" ], "interventions": [ { "name": "Atenolol", "type": "DRUG" }, { "name": "Losartan", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Brigham and Women's Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "25 Years", "maximum_age": null, "sex": "ALL", "summary": "25 Years and older" }, "enrollment_count": 40, "start_date": "2007-10", "completion_date": "2012-12", "has_results": true, "last_update_posted_date": "2014-09-09", "last_synced_at": "2026-09-27T19:11:12.618Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT00723801" }, { "nct_id": "NCT03467217", "title": "Losartan for the Treatment of Pediatric NAFLD", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "NAFLD - Nonalcoholic Fatty Liver Disease" ], "interventions": [ { "name": "Losartan potassium", "type": "DRUG" }, { "name": "Placebo losartan capsule", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "8 Years", "maximum_age": "17 Years", "sex": "ALL", "summary": "8 Years to 17 Years" }, "enrollment_count": 83, "start_date": "2018-10-02", "completion_date": "2020-06-30", "has_results": true, "last_update_posted_date": "2021-10-21", "last_synced_at": "2026-09-27T19:11:12.618Z", "location_count": 10, "location_summary": "San Diego, California • San Francisco, California • Atlanta, Georgia + 7 more", "locations": [ { "city": "San Diego", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Indianapolis", "state": "Indiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT03467217" }, { "nct_id": "NCT02495077", "title": "Effects of Inhibiting Early Inflammation in Kidney Transplant Patients", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Kidney Transplant" ], "interventions": [ { "name": "Infliximab", "type": "BIOLOGICAL" }, { "name": "Methylprednisolone", "type": "DRUG" }, { "name": "Mycophenolate Mofetil", "type": "DRUG" }, { "name": "Tacrolimus", "type": "DRUG" }, { "name": "Thymoglobulin®", "type": "BIOLOGICAL" }, { "name": "Acetaminophen", "type": "DRUG" }, { "name": "Loratadine", "type": "DRUG" }, { "name": "Placebo for Infliximab", "type": "BIOLOGICAL" }, { "name": "Prednisone", "type": "DRUG" }, { "name": "Diphenhydramine", "type": "DRUG" } ], "intervention_types": [ "BIOLOGICAL", "DRUG" ], "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 290, "start_date": "2015-11-02", "completion_date": "2021-07-23", "has_results": true, "last_update_posted_date": "2026-09-24", "last_synced_at": "2026-09-27T19:11:12.618Z", "location_count": 13, "location_summary": "Birmingham, Alabama • Los Angeles, California • San Francisco, California + 8 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Los Angeles", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "New Haven", "state": "Connecticut" }, { "city": "Atlanta", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT02495077" }, { "nct_id": "NCT01847001", "title": "Study of Propranolol in Newly Diagnosed Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Locally Advanced Malignant Neoplasm", "Breast Cancer" ], "interventions": [ { "name": "Propranolol", "type": "DRUG" }, { "name": "DOT imaging", "type": "OTHER" }, { "name": "Paclitaxel", "type": "DRUG" }, { "name": "Nab-paclitaxel", "type": "DRUG" }, { "name": "Trastuzumab", "type": "DRUG" }, { "name": "Pertuzumab", "type": "DRUG" }, { "name": "Doxorubicin", "type": "DRUG" }, { "name": "Cyclophosphamide", "type": "DRUG" }, { "name": "Surgery", "type": "PROCEDURE" }, { "name": "Premedication", "type": "DRUG" }, { "name": "Anti-nausea therapy", "type": "DRUG" }, { "name": "Pegfilgrastim", "type": "DRUG" } ], "intervention_types": [ "DRUG", "OTHER", "PROCEDURE" ], "sponsor": "Columbia University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 10, "start_date": "2012-10", "completion_date": "2019-10-16", "has_results": true, "last_update_posted_date": "2021-09-10", "last_synced_at": "2026-09-27T19:11:12.618Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT01847001" }, { "nct_id": "NCT01455389", "title": "TUSC2-nanoparticles and Erlotinib in Stage IV Lung Cancer", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Lung Cancer" ], "interventions": [ { "name": "DOTAP:Chol-TUSC2", "type": "DRUG" }, { "name": "Erlotinib", "type": "DRUG" }, { "name": "Dexamethasone", "type": "DRUG" }, { "name": "Diphenhydramine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Genprex, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 25, "start_date": "2014-02", "completion_date": "2020-09-28", "has_results": false, "last_update_posted_date": "2022-03-02", "last_synced_at": "2026-09-27T19:11:12.618Z", "location_count": 1, "location_summary": "Houston, Texas", "locations": [ { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01455389" }, { "nct_id": "NCT02023164", "title": "Pilot Phase III Clinical Trial of JDP-205 IV Injection for Treatment of Acute Urticaria", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Acute Urticaria" ], "interventions": [ { "name": "JDP-205 Injection", "type": "DRUG" }, { "name": "Diphenhydramine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "JDP Therapeutics, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 36, "start_date": "2013-07", "completion_date": "2014-12", "has_results": true, "last_update_posted_date": "2024-02-09", "last_synced_at": "2026-09-27T19:11:12.618Z", "location_count": 2, "location_summary": "Cincinnati, Ohio • Columbus, Ohio", "locations": [ { "city": "Cincinnati", "state": "Ohio" }, { "city": "Columbus", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT02023164" } ] }